Showing 38,141 - 38,160 results of 118,456 for search '(( a mean decrease ) OR ( 5 ((wt decrease) OR (((nn decrease) OR (a decrease)))) ))', query time: 1.70s Refine Results
  1. 38141

    Studied interconnected systems. by Mahmoud M. Hussein (16965014)

    Published 2023
    “…Both of these components are designed for autonomous vehicle-to-grid (V2G) devices. The proposed control technique is applied to a three-area power system, where the V2G scheme is located in Area-1. …”
  2. 38142

    Frequency responses for case 3. by Mahmoud M. Hussein (16965014)

    Published 2023
    “…Both of these components are designed for autonomous vehicle-to-grid (V2G) devices. The proposed control technique is applied to a three-area power system, where the V2G scheme is located in Area-1. …”
  3. 38143

    Fluctuation sources for case 3. by Mahmoud M. Hussein (16965014)

    Published 2023
    “…Both of these components are designed for autonomous vehicle-to-grid (V2G) devices. The proposed control technique is applied to a three-area power system, where the V2G scheme is located in Area-1. …”
  4. 38144

    Configuration of the interconnected power system. by Mahmoud M. Hussein (16965014)

    Published 2023
    “…Both of these components are designed for autonomous vehicle-to-grid (V2G) devices. The proposed control technique is applied to a three-area power system, where the V2G scheme is located in Area-1. …”
  5. 38145

    Block diagram of the studied system using RTS. by Mahmoud M. Hussein (16965014)

    Published 2023
    “…Both of these components are designed for autonomous vehicle-to-grid (V2G) devices. The proposed control technique is applied to a three-area power system, where the V2G scheme is located in Area-1. …”
  6. 38146

    Supplementary materials: A matching-adjusted indirect comparison of centanafadine versus lisdexamfetamine, methylphenidate and atomoxetine in adults with attention-deficit/hyperact... by Jeff Schein (3413771)

    Published 2024
    “…<b>Patients & methods: </b>Patient-level data from a centanafadine trial (NCT03605849) and published aggregate data from a lisdexamfetamine trial (NCT00337285), a methylphenidate trial (NCT00326300) and an atomoxetine trial (NCT00190736) were used. …”
  7. 38147
  8. 38148

    Image_1_Opposite trends in incidence of breast cancer in young and old female cohorts in Hungary and the impact of the Covid-19 pandemic: a nationwide study between 2011–2020.jpeg... by Zoltán Kiss (5570003)

    Published 2023
    “…Age-standardized incidence rates varied between 116.73 and 106.16/100,000 PYs, showing a mean annual change of -0.7% (95% CI: -1.21%–0.16%) and a total change of -5.41% (95% CI: -9.24 to -1.32). …”
  9. 38149

    Covalent <i>Plasmodium falciparum</i>-selective proteasome inhibitors exhibit a low propensity for generating resistance <i>in vitro</i> and synergize with multiple antimalarial ag... by Barbara H. Stokes (5697422)

    Published 2019
    “…These results underscore the potential of targeting the <i>Plasmodium</i> proteasome with covalent small molecule inhibitors as a means of combating multidrug-resistant malaria.…”
  10. 38150

    Presentation 1_Case Report: Full recovery in severe ParvovirusB19 myocarditis with DCM phenotype: the impact of rASD and PAB.pptx by T. Logeswaran (21495341)

    Published 2025
    “…The pressure gradient across the PAB ranged from 40 to 45 mmHg, and LVEDD decreased to a mean z-score of +3.5. Within three to six months, LVEDD normalized, and LV-EF increased to a mean of 63% (range: 57%–68%). …”
  11. 38151
  12. 38152
  13. 38153
  14. 38154
  15. 38155

    Morphology, mechanical property, and molten pool dynamics in spot modulated-PLBW of Ti6Al4V alloy sheets with air gap condition by Jicheng Chen (485474)

    Published 2023
    “…Herein, an improved laser welding scheme, integrating the pulsed laser power and the modulated beam spot size is developed and applied on 1.5 mm-thick Ti6Al4V sheets with a predetermined air gap range. …”
  16. 38156
  17. 38157

    6:2 Chlorinated Polyfluoroalkyl Ether Sulfonate (F-53B) Induces Aging and Parkinson’s Disease-like Disorders in <i>C. elegans</i> at Low Concentrations by Hui Li (32376)

    Published 2025
    “…After exposure to F-53B at 2, 10, and 50 ng/L, C. elegans showed an aging phenomenon as lipofuscin was significantly increased by 48.7–57.5% and locomotion, such as center point speed, was significantly decreased in all exposure groups. …”
  18. 38158

    6:2 Chlorinated Polyfluoroalkyl Ether Sulfonate (F-53B) Induces Aging and Parkinson’s Disease-like Disorders in <i>C. elegans</i> at Low Concentrations by Hui Li (32376)

    Published 2025
    “…After exposure to F-53B at 2, 10, and 50 ng/L, C. elegans showed an aging phenomenon as lipofuscin was significantly increased by 48.7–57.5% and locomotion, such as center point speed, was significantly decreased in all exposure groups. …”
  19. 38159

    6:2 Chlorinated Polyfluoroalkyl Ether Sulfonate (F-53B) Induces Aging and Parkinson’s Disease-like Disorders in <i>C. elegans</i> at Low Concentrations by Hui Li (32376)

    Published 2025
    “…After exposure to F-53B at 2, 10, and 50 ng/L, C. elegans showed an aging phenomenon as lipofuscin was significantly increased by 48.7–57.5% and locomotion, such as center point speed, was significantly decreased in all exposure groups. …”
  20. 38160

    6:2 Chlorinated Polyfluoroalkyl Ether Sulfonate (F-53B) Induces Aging and Parkinson’s Disease-like Disorders in <i>C. elegans</i> at Low Concentrations by Hui Li (32376)

    Published 2025
    “…After exposure to F-53B at 2, 10, and 50 ng/L, C. elegans showed an aging phenomenon as lipofuscin was significantly increased by 48.7–57.5% and locomotion, such as center point speed, was significantly decreased in all exposure groups. …”